Literature DB >> 11442275

Lyophilized lecithin based oil-water microemulsions as a new and low toxic delivery system for amphotericin B.

M A Moreno1, P Frutos, M P Ballesteros.   

Abstract

PURPOSE: To develop and investigate lecithin based oil-water microemulsions as potential amphotericin B (AmB) delivery systems and to evaluate their in vivo acute toxicity.
METHODS: AmB was added to the microemulsion and its location was evaluated by partitioning studies and UV-visible spectrophotometric analysis of the drug. Both, non-lyophilized and reconstituted microemulsions were characterised and assessed for their stability. Single-dose acute toxicity of the AmB microemulsion was studied on male albino Webster-derived CD-1 mice and compared with Fungizone.
RESULTS: The studies performed showed that AmB was intercalated on the oil-water interface of the microemulsion as a complex formed with lecithin molecules. AmB addition did not seem to modify the rheological properties of the original system, but had an effect on its particle size distribution. Lyophilization of the microemulsion led to an oily cake, easily reconstituted and stable at the conditions studied. Single-dose acute toxicity studies proved that the LD50 of AmB microemulsions was of 4 mg kg(-1) of animal weight, compared with 1 mg kg(-1) found for Fungizone.
CONCLUSIONS: Lyophilized lecithin based oil-water microemulsions appear to be valuable systems for the delivery of AmB in terms of easy and low-cost manufacturing, stability and safety compared with the formulations already in market.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442275     DOI: 10.1023/a:1011011215418

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

Review 1.  Liposomes as carriers of antimicrobial agents.

Authors:  G Lopez-Berestein
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

Review 2.  Disseminated fusarial infection in the immunocompromised host.

Authors:  S E Richardson; R M Bannatyne; R C Summerbell; J Milliken; R Gold; S S Weitzman
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

Review 3.  Nephrotoxicity of amphotericin B.

Authors:  M A Carlson; R E Condon
Journal:  J Am Coll Surg       Date:  1994-09       Impact factor: 6.113

4.  An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis.

Authors:  R Kirsh; R Goldstein; J Tarloff; D Parris; J Hook; N Hanna; P Bugelski; G Poste
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

5.  The use of amphotericin B in nosocomial fungal infection.

Authors:  J R Perfect; W W Pickard; D L Hunt; B Palmer; W A Schell
Journal:  Rev Infect Dis       Date:  1991 May-Jun

6.  Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes.

Authors:  P Legrand; E A Romero; B E Cohen; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

7.  [Emulsion of amphotericin B in Intralipid 20%: in vitro and in vivo efficacy].

Authors:  P Chavanet; N Charlier; A Brenet; A Goux; E Muggéo; D Caillot; O Casasnovas; J P Kistermann; A Waldner; H Portier
Journal:  Pathol Biol (Paris)       Date:  1992-05

8.  Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B: lipid state and cholesterol content dependence.

Authors:  J Bolard; M Seigneuret; G Boudet
Journal:  Biochim Biophys Acta       Date:  1980-06-20

9.  Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice.

Authors:  G Lopez-Berestein; R L Hopfer; R Mehta; K Mehta; E M Hersh; R L Juliano
Journal:  J Infect Dis       Date:  1984-08       Impact factor: 5.226

10.  Hydrolysis of partially saturated egg phosphatidylcholine in aqueous liposome dispersions and the effect of cholesterol incorporation on hydrolysis kinetics.

Authors:  M Grit; N J Zuidam; W J Underberg; D J Crommelin
Journal:  J Pharm Pharmacol       Date:  1993-06       Impact factor: 3.765

View more
  4 in total

1.  Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.

Authors:  J A Sánchez-Brunete; M A Dea; S Rama; F Bolás; J M Alunda; R Raposo; M T Méndez; S Torrado-Santiago; J J Torrado
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  Formulation and evaluation of microemulsion based delivery system for amphotericin B.

Authors:  Pradnya S Darole; Darshana D Hegde; Hema A Nair
Journal:  AAPS PharmSciTech       Date:  2008-01-18       Impact factor: 3.246

3.  Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system.

Authors:  Tatiana G Ribeiro; Miguel A Chávez-Fumagalli; Diogo G Valadares; Juçara R França; Lívia B Rodrigues; Mariana C Duarte; Paula S Lage; Pedro H R Andrade; Daniela P Lage; Leonardo V Arruda; Daniel R Abánades; Lourena E Costa; Vivian T Martins; Carlos A P Tavares; Rachel O Castilho; Eduardo A F Coelho; André A G Faraco
Journal:  Int J Nanomedicine       Date:  2014-02-14

4.  Preparation and evaluation of microemulsion‑based transdermal delivery of Cistanche tubulosa phenylethanoid glycosides.

Authors:  Jianhua Yang; Huanhuan Xu; Shanshan Wu; Bowei Ju; Dandan Zhu; Yao Yan; Mei Wang; Junping Hu
Journal:  Mol Med Rep       Date:  2017-01-25       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.